NextCure to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

A recording of the webcast will be available on the conference day starting at 7 AM ET through the Investors section of the company's website at www.nextcure.com. The webcast will be available on the website for 30 days. NextCure, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies in cancer, including NC410, a LAIR-2 fusion protein, and LNCB74, a novel ADC targeting B7-H4. The Company also has a non-oncology preclinica ...